| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-06 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-06 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.23 | 1e-05 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.14 | 3e-05 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.14 | 7e-05 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.13 | 8e-05 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.18 | 0.0002 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |